These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 29736148

  • 21. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH, Kim YM, Lee GM, Yu J, Han HS, Yu J.
    J Korean Med Sci; 2022 Mar 21; 37(11):e90. PubMed ID: 35315601
    [Abstract] [Full Text] [Related]

  • 22. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
    Ballerini MG, Braslavsky D, Scaglia PA, Keselman A, Rodríguez ME, Martínez A, Freire AV, Domené HM, Jasper HG, Bergadá I, Ropelato MG.
    Horm Res Paediatr; 2017 Mar 21; 88(5):354-363. PubMed ID: 28926833
    [Abstract] [Full Text] [Related]

  • 23. Response to growth hormone according to provocation test results in idiopathic short stature and idiopathic growth hormone deficiency.
    Yoon JY, Cheon CK, Lee JH, Kwak MJ, Kim HJ, Kim YJ, Lee JE, Chung WY, Kim J, Yoo JH.
    Ann Pediatr Endocrinol Metab; 2022 Mar 21; 27(1):37-43. PubMed ID: 35038835
    [Abstract] [Full Text] [Related]

  • 24. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
    Su Z, Li YH, Ma HM, Chen HS, DU ML, Gu YF.
    Zhonghua Er Ke Za Zhi; 2008 Oct 21; 46(10):757-62. PubMed ID: 19099881
    [Abstract] [Full Text] [Related]

  • 25. Comparison of growth hormone treatment in patients with idiopathic short stature and idiopathic growth hormone deficiency.
    Kim SA, Choe YR, Yang EM, Kim CJ.
    Chonnam Med J; 2014 Aug 21; 50(2):63-6. PubMed ID: 25229018
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Basal characteristics and first year responses to human growth hormone (GH) vary according to diagnostic criteria in children with non-acquired GH deficiency (naGHD): observations from a single center over a period of five decades.
    Ranke MB, Schweizer R, Binder G.
    J Pediatr Endocrinol Metab; 2018 Nov 27; 31(11):1257-1266. PubMed ID: 30332395
    [Abstract] [Full Text] [Related]

  • 30. No Improvement of Adult Height in Non-growth Hormone (GH) Deficient Short Children with GH Treatment.
    Tanaka T, Fujieda K, Yokoya S, Shimatsu A, Tachibana K, Tanaka H, Tanizawa T, Teramoto A, Nagai T, Nishi Y, Hasegawa Y, Hanew K, Fujita K, Horikawa R, Takada G, Miyashita M, Ohno T, Komatsu K.
    Clin Pediatr Endocrinol; 2006 Nov 27; 15(1):15-21. PubMed ID: 24790315
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A, González L, Gunczler P, Lanes R.
    J Pediatr Endocrinol Metab; 2012 Nov 27; 25(7-8):651-7. PubMed ID: 23155689
    [Abstract] [Full Text] [Related]

  • 33. Characteristics of children with the best and poorest first- and second-year growth during rhGH therapy: data from 25 years of the Genentech national cooperative growth study (NCGS).
    Kaplowitz PB, Shulman DI, Frane JW, Jacobs J, Lippe B.
    Int J Pediatr Endocrinol; 2013 May 01; 2013(1):9. PubMed ID: 23631505
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW.
    Zhonghua Er Ke Za Zhi; 2009 Jan 01; 47(1):48-52. PubMed ID: 19573383
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
    Darendeliler F, Lindberg A, Wilton P.
    Horm Res Paediatr; 2011 Jan 01; 76 Suppl 1():42-6. PubMed ID: 21778748
    [Abstract] [Full Text] [Related]

  • 38. Growth hormone prescribing and initial BMI SDS: Increased biochemical adverse effects and costs in obese children without additional gain in height.
    Hawcutt DB, Bellis J, Price V, Povall A, Newland P, Richardson P, Peak M, Blair J.
    PLoS One; 2017 Jan 01; 12(7):e0181567. PubMed ID: 28715498
    [Abstract] [Full Text] [Related]

  • 39. Clinical Characteristics and Long-Term Recombinant Human Growth Hormone Treatment of 18q- Syndrome: A Case Report and Literature Review.
    Liu S, Chen M, Yang H, Chen S, Wang L, Duan L, Zhu H, Pan H.
    Front Endocrinol (Lausanne); 2021 Jan 01; 12():776835. PubMed ID: 34956087
    [Abstract] [Full Text] [Related]

  • 40. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
    Rachmiel M, Rota V, Atenafu E, Daneman D, Hamilton J.
    Horm Res; 2007 Jan 01; 68(5):236-43. PubMed ID: 17396034
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.